Fundz

N-Power Medicine Collaborates with Merck to Expand Oncologist and Patient Access to Clinical Trials

Jul 01, 2024

Contract Type

partnership

Redwood CityBiotechnologyHealth CareMedicalTherapeuticsPharmaceutical

Description

N-Power Medicine and Merck are collaborating to enable a greater number of oncologists and the patients they care for to participate in clinical research, aiming to broaden the new model for clinical development to other indications within oncology as the N-Power Medicine Network grows.

Company Information

Company

N-Power Medicine

Location

Redwood City, California, United States

About

N-Power Medicine is a clinical research and drug development platform company that aims to integrate clinical research and routine care into a single workflow. Founded in 2021, it aims to boost clinical trial participation to accelerate oncology drug development. The company's platform includes The Kaleido Registry, a collection of prospective, real-time, standardized patient data designed to support clinical trials and drug development.

Related People

Mark
Likely contact at this company
••••••••@••••••••

See Mark's verified email →

Maria
Likely contact at this company
••••••••@••••••••

See Maria's verified email →

Mark
Senior decision-maker at this company
••••••••@••••••••

See Mark's verified email →

Martin
Senior decision-maker at this company
••••••••@••••••••

See Martin's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for N-Power Medicine's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

N-Power Medicine signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.